Hepatitis B Virus NAT Positive Donors in Non‐Hepatic Organ Transplant: Quantifying Viral Loads to Optimize Recipient Risk Stratification and Management in the Prevention of Donor‐Derived Infection

Ähnliche Einträge

• Hepatitis B Virus Donor Positive to Recipient Negative (D+/R−) Heart and Lung Transplantation: Analysis From the Organ Procurement and Transplantation Network
  von: Sara Belga, et al.
  Veröffentlicht: (2025)
• Contemporary Cytomegalovirus (CMV) Infections in Low‐Risk CMV Seronegative Recipients of Solid Organ Transplants From CMV Seronegative Donors (D−/R−): Time to Reexamine Donor CMV Serostatus
  von: Madeleine R. Heldman, et al.
  Veröffentlicht: (2024)
• Clinical Utility of Donor‐Derived Cell‐Free DNA in Heart Transplant Recipients With Multi‐Organ Transplants
  von: Cathrine M. Moeller, et al.
  Veröffentlicht: (2024)
• Transmission of Ehrlichia chaffeensis From an Organ Donor to a Kidney–Pancreas Transplant Recipient
  von: Praveen Gundelly, et al.
  Veröffentlicht: (2025)
• Hepatitis B Vaccine Compliance, Serologic Response, and Durability in Adult Thoracic Organ Transplant Recipients
  von: Chia‐Yu Chiu, et al.
  Veröffentlicht: (2024)